...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Activated caspase-1 is not a central mediator of inflammation in the course of ischemia-reperfusion.
【24h】

Activated caspase-1 is not a central mediator of inflammation in the course of ischemia-reperfusion.

机译:在缺血再灌注过程中,活化的caspase-1不是炎症的主要介质。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Upon transplantation, donor organs subjected to prolonged ischemia suffer from reperfusion injury. Recent observations suggest that caspase activation is involved in inducing the deleterious inflammatory reaction that mediates reperfusion injury. Release of cytokines like interleukin (IL)-1 and IL-18 may occur during apoptosis through activation of caspase-1/IL-1beta-converting enzyme. We hypothesized that caspase-1 activation is a key event in apoptosis/ caspase-dependent inflammation during the development of renal reperfusion injury. METHODS: Caspase-1-/-, caspase-1+/+ as well as Swiss mice were subjected to 45 min of renal ischemia and 24 hr of reperfusion. Animals were administered agents capable of neutralizing the pro-inflammatory activation products of caspase-1 (IL-1 receptor antagonist, anti-IL-1 receptor antibody, and anti-IL-18 antibody). The extent of renal functional deterioration, inflammation, and apoptosis were compared. RESULTS: No improvement in renal function as reflected by serum ureum and creatinine were found in caspase-1-/- mice as compared to wild type controls. Caspase-1-/- mice showed slightly attenuated renal inflammation as indicated by decreased renal neutrophil influx, but failed to show changes in intrarenal tumor necrosis factor-alpha production. Moreover, caspase-1-/- mice clearly exhibited reperfusion-induced apoptosis as reflected by renal terminal deoxynucleotidyltransferase histology and internucleosomal DNA cleavage. Treatment with IL-1 receptor antagonist, anti-IL-1 receptor antibody, or anti-IL-18 antibody minimally reduced renal functional deterioration, inflammation, and apoptosis. CONCLUSIONS: These findings suggest that activated caspase-1 and its inflammatory products are involved in, but not crucial to, the induction of inflammation after renal ischemia-reperfusion. Hence, apart from caspase-1, other (combinations of) activated caspases are likely to be more prominently involved in renal reperfusion injury.
机译:背景:移植后,经历长时间缺血的供体器官会受到再灌注损伤。最近的观察表明,胱天蛋白酶的活化参与诱导介导再灌注损伤的有害炎症反应。通过激活caspase-1 / IL-1beta转换酶,在凋亡过程中可能发生白介素(IL)-1和IL-18等细胞因子的释放。我们假设caspase-1激活是肾脏再灌注损伤发展过程中凋亡/ caspase依赖性炎症中的关键事件。方法:对Caspase-1-/-,caspase-1 + / +以及瑞士小鼠进行45分钟的肾脏缺血和24小时的再灌注。给动物施用能够中和caspase-1的促炎激活产物的试剂(IL-1受体拮抗剂,抗IL-1受体抗体和抗IL-18抗体)。比较了肾功能恶化,炎症和凋亡的程度。结果:与野生型对照组相比,在caspase-1-/-小鼠中未发现血清尿素和肌酐能反映肾脏功能的改善。 Caspase-1-/-小鼠显示出肾中性粒细胞流入减少,从而减轻了肾脏的炎症反应,但未能显示出肾内肿瘤坏死因子-α产生的变化。此外,caspase-1-/-小鼠明显表现出再灌注诱导的凋亡,如肾脏末端脱氧核苷酸转移酶组织学和核小体间DNA切割所反映。用IL-1受体拮抗剂,抗IL-1受体抗体或抗IL-18抗体治疗可最小程度地降低肾功能恶化,炎症和细胞凋亡。结论:这些发现表明,活化的caspase-1及其炎症产物与肾脏缺血-再灌注后炎症的诱导有关,但并非至关重要。因此,除了caspase-1外,其他激活的半胱天冬酶(的组合)可能更明显地参与肾脏再灌注损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号